ID   GRU-1
AC   CVCL_N845
SY   GRU-I
DR   Wikidata; Q54871702
RX   PubMed=1688830;
RX   PubMed=7525493;
CC   Doubling time: 29 hours (PubMed=1688830); 17 hours (PubMed=7525493).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
RX   PubMed=1688830; DOI=10.1002/ijc.2910450126;
RA   Gerharz C.-D., Moll R., Ramp U., Mellin W., Gabbert H.E.;
RT   "Multidirectional differentiation in a newly established human
RT   epithelioid sarcoma cell line (GRU-1) with co-expression of vimentin,
RT   cytokeratins and neurofilament proteins.";
RL   Int. J. Cancer 45:143-152(1990).
//
RX   PubMed=7525493; DOI=10.1002/ijc.2910590419;
RA   Engers R., Gerharz C.-D., Moll R., Pohl A., Sarbia M., Gabbert H.E.;
RT   "Interclonal heterogeneity in a human epithelioid-sarcoma cell line
RT   (GRU-1).";
RL   Int. J. Cancer 59:548-553(1994).
//